Tapewire

Nasdaq · USD

PTCT

PTC THERAPEUTICS, INC.

Export transactions ↓
Tapewire entity
3803
SEC CIK
0001070081
Parsed reports
477

Last 12 months

Inside the activity.

0 purchase rows · 202 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025039
Dec 2025021
Jan 2026042
Feb 2026014
Mar 202606
Apr 202607
May 2026010
Jun 2026018
Jul 2026020
Aug 2026012
Sep 202608
Oct 202605

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 07, 2026 Filed Jan 8, 2026 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
SaleCommon Stock 471 $77.10 $36,314.10
Disclosure

SEC source: 0001578852-26-000004 · form4-01082026_050104.xml · nonDerivative · entry 8

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 117,939

F3 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.

F6 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.54 to $77.52 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
Exercise / conversionCommon Stock 751 $38.10 $28,613.10
Disclosure

SEC source: 0001578852-26-000004 · form4-01082026_050104.xml · nonDerivative · entry 7

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,410

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
SaleCommon Stock 38 $78.60 $2,986.80
Disclosure

SEC source: 0001578852-26-000004 · form4-01082026_050104.xml · nonDerivative · entry 6

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 117,659

F3 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
SaleCommon Stock 949 $77.91 $73,936.59
Disclosure

SEC source: 0001578852-26-000004 · form4-01082026_050104.xml · nonDerivative · entry 5

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 117,697

F3 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.

F5 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $77.58 to $78.54 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
SaleCommon Stock 1,638 $77.11 $126,306.18
Disclosure

SEC source: 0001578852-26-000004 · form4-01082026_050104.xml · nonDerivative · entry 4

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,646

F3 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.

F4 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.56 to $77.55 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
Exercise / conversionCommon Stock 2,625 $38.10 $100,012.50
Disclosure

SEC source: 0001578852-26-000004 · form4-01082026_050104.xml · nonDerivative · entry 3

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,284

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
SaleCommon Stock 1,503 $77.48 $116,452.44
Disclosure

SEC source: 0001578852-26-000004 · form4-01082026_050104.xml · nonDerivative · entry 2

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 117,659

F2 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,250 RSUs from a January 5, 2023 grant of 17,000 RSUs.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
SaleCommon Stock 52 $77.48 $4,028.96
Disclosure

SEC source: 0001578850-26-000004 · form4-01082026_050101.xml · nonDerivative · entry 4

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 6,850

F4 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 177 RSUs from a January 5, 2023 grant of 710 RSUs.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
SaleCommon Stock 1,026 $77.48 $79,494.48
Disclosure

SEC source: 0001578850-26-000004 · form4-01082026_050101.xml · nonDerivative · entry 3

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,077

F3 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,250 RSUs from a January 5, 2023 grant of 17,000 RSUs.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 22:20 UTC
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
SaleCommon Stock 1,381 $76.95 $106,267.95
Disclosure

SEC source: 0001707685-26-000004 · form4-01082026_050123.xml · nonDerivative · entry 1

Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,962

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 3,500 RSUs from a January 3, 2025 grant of 14,000 RSUs.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 22:20 UTC
Gravier PierreCHIEF FINANCIAL OFFICER
SaleCommon Stock 2,139 $76.95 $164,596.05
Disclosure

SEC source: 0001984065-26-000004 · form4-01082026_050121.xml · nonDerivative · entry 1

Gravier Pierre · CIK 0001984065 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 90,310

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 5,625 RSUs from a January 3, 2025 grant of 22,500 RSUs

Read SEC document
January 06, 2026 Filed Jan 8, 2026 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 1,789 $76.95 $137,663.55
Disclosure

SEC source: 0001323212-26-000004 · form4-01082026_050119.xml · nonDerivative · entry 1

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 88,841

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 5,500 RSUs from a January 3, 2025 grant of 22,000 RSUs.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 22:20 UTC
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 5,149 $76.95 $396,215.55
Disclosure

SEC source: 0001808968-26-000005 · form4-01082026_050118.xml · nonDerivative · entry 1

Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 399,983

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 17,500 RSUs from a January 3, 2025 grant of 70,000 RSUs.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 22:20 UTC
Golden Lee ScottEVP & CHIEF MEDICAL OFFICER
SaleCommon Stock 1,340 $76.95 $103,113.00
Disclosure

SEC source: 0001686217-26-000004 · form4-01082026_050106.xml · nonDerivative · entry 1

Golden Lee Scott · CIK 0001686217 · EVP & CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 93,936

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 5,000 RSUs from a January 3, 2025 grant of 20,000 RSUs.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
SaleCommon Stock 1,739 $76.95 $133,816.05
Disclosure

SEC source: 0001578852-26-000004 · form4-01082026_050104.xml · nonDerivative · entry 1

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,162

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,500 RSUs from a January 3, 2025 grant of 18,000 RSUs.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
SaleCommon Stock 54 $76.95 $4,155.30
Disclosure

SEC source: 0001578850-26-000004 · form4-01082026_050101.xml · nonDerivative · entry 2

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 6,902

F2 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 178 RSUs from a January 3, 2025 grant of 715 RSUs.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
SaleCommon Stock 1,279 $76.95 $98,419.05
Disclosure

SEC source: 0001578850-26-000004 · form4-01082026_050101.xml · nonDerivative · entry 1

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 117,103

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,750 RSUs from a January 3, 2025 grant of 19,000 RSUs.

Read SEC document
January 05, 2026 Filed Jan 6, 2026 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
Exercise / conversionStock Option (Right to Buy) · Derivative 2,266 $0.00 Strike: $39.42 $0.00
Disclosure

SEC source: 0001578852-26-000002 · form4-01062026_050119.xml · derivative · entry 7

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,063

Underlying: Common Stock · 2,266 shares

Expires 2033-01-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.

F7 · derivative.exercise_date: This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024.

Read SEC document
January 05, 2026 Filed Jan 6, 2026 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
SaleCommon Stock 108 $76.79 $8,293.32
Disclosure

SEC source: 0001578852-26-000002 · form4-01062026_050119.xml · nonDerivative · entry 5

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,901

F2 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.

F5 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.75 to $76.81 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
January 05, 2026 Filed Jan 6, 2026 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
SaleCommon Stock 1,035 $76.10 $78,763.50
Disclosure

SEC source: 0001578852-26-000002 · form4-01062026_050119.xml · nonDerivative · entry 4

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 121,009

F2 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.

F4 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.58 to $76.42 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
January 05, 2026 Filed Jan 6, 2026 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
SaleCommon Stock 1,123 $74.92 $84,135.16
Disclosure

SEC source: 0001578852-26-000002 · form4-01062026_050119.xml · nonDerivative · entry 3

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 122,044

F2 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.

F3 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $74.55 to $75.27 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
January 05, 2026 Filed Jan 6, 2026 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
Exercise / conversionCommon Stock 2,266 $39.42 $89,325.72
Disclosure

SEC source: 0001578852-26-000002 · form4-01062026_050119.xml · nonDerivative · entry 2

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 123,167

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.

Read SEC document
January 05, 2026 Filed Jan 6, 2026 22:20 UTC
Reeve EmmaDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 734 $0.00 Strike: $46.54 $0.00
Disclosure

SEC source: 0001680329-26-000002 · form4-01062026_050117.xml · derivative · entry 5

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 734 shares

Expires 2035-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.

F4 · derivative.exercise_date: Currently exercisable.

Read SEC document
January 05, 2026 Filed Jan 6, 2026 22:20 UTC
Reeve EmmaDirector
SaleCommon Stock 734 $76.00 $55,784.00
Disclosure

SEC source: 0001680329-26-000002 · form4-01062026_050117.xml · nonDerivative · entry 3

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,666

F2 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.

Read SEC document
January 05, 2026 Filed Jan 6, 2026 22:20 UTC
Reeve EmmaDirector
Exercise / conversionCommon Stock 734 $46.54 $34,160.36
Disclosure

SEC source: 0001680329-26-000002 · form4-01062026_050117.xml · nonDerivative · entry 2

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,400

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:23 UTC GrantStock Option (Right to Buy) · Derivative 3,475 $0.00 Strike: $76.74 $0.00
Disclosure

SEC source: 0001866044-26-000003 · form4-01062026_100143.xml · derivative · entry 2

Smith Mary L. · CIK 0001866044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,475

Underlying: Common Stock · 3,475 shares

Expires 2036-01-01

F2 · derivative.exercise_date: This option was granted on January 2, 2026 and vests over one year in twelve equal monthly installments, commencing on February 2, 2026.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:23 UTC GrantCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001866044-26-000003 · form4-01062026_100143.xml · nonDerivative · entry 1

Smith Mary L. · CIK 0001866044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,813

F1 · shares: Restricted stock units granted on January 2, 2026 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 2, 2026 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 2, 2027.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
GrantStock Option (Right to Buy) · Derivative 43,750 $0.00 Strike: $76.74 $0.00
Disclosure

SEC source: 0001578850-26-000002 · form4-01062026_050126.xml · derivative · entry 3

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,750

Underlying: Common Stock · 43,750 shares

Expires 2036-01-01

F3 · derivative.exercise_date: This option was granted on January 2, 2026, and vests over four years, with 25% of the shares underlying the option vesting on January 2, 2027, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2027.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
GrantCommon Stock 520 $0.00 $0.00
Disclosure

SEC source: 0001578850-26-000002 · form4-01062026_050126.xml · nonDerivative · entry 2

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 6,956

F1 · shares: Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027.

F2 · balance_after: Includes 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
GrantCommon Stock 17,500 $0.00 $0.00
Disclosure

SEC source: 0001578850-26-000002 · form4-01062026_050126.xml · nonDerivative · entry 1

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,382

F1 · shares: Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027.

F2 · balance_after: Includes 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
GrantStock Option (Right to Buy) · Derivative 33,125 $0.00 Strike: $76.74 $0.00
Disclosure

SEC source: 0001707685-26-000002 · form4-01062026_050124.xml · derivative · entry 2

Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,125

Underlying: Common Stock · 33,125 shares

Expires 2036-01-01

F3 · derivative.exercise_date: This option was granted on January 2, 2026, and vests over four years, with 25% of the shares underlying the option vesting on January 2, 2027, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2027.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
GrantCommon Stock 13,250 $0.00 $0.00
Disclosure

SEC source: 0001707685-26-000002 · form4-01062026_050124.xml · nonDerivative · entry 1

Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,343

F1 · shares: Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027.

F2 · balance_after: Includes 272 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2025, and 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC
Golden Lee ScottEVP & CHIEF MEDICAL OFFICER
GrantStock Option (Right to Buy) · Derivative 46,875 $0.00 Strike: $76.74 $0.00
Disclosure

SEC source: 0001686217-26-000002 · form4-01062026_050122.xml · derivative · entry 2

Golden Lee Scott · CIK 0001686217 · EVP & CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,875

Underlying: Common Stock · 46,875 shares

Expires 2036-01-01

F3 · derivative.exercise_date: This option was granted on January 2, 2026, and vests over four years, with 25% of the shares underlying the option vesting on January 2, 2027, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2027.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC
Golden Lee ScottEVP & CHIEF MEDICAL OFFICER
GrantCommon Stock 18,750 $0.00 $0.00
Disclosure

SEC source: 0001686217-26-000002 · form4-01062026_050122.xml · nonDerivative · entry 1

Golden Lee Scott · CIK 0001686217 · EVP & CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,276

F1 · shares: Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027.

F2 · balance_after: Includes 272 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2025, and 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $76.74 $0.00
Disclosure

SEC source: 0001323212-26-000002 · form4-01062026_050121.xml · derivative · entry 2

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2036-01-01

F3 · derivative.exercise_date: This option was granted on January 2, 2026, and vests over four years, with 25% of the shares underlying the option vesting on January 2, 2027, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2027.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001323212-26-000002 · form4-01062026_050121.xml · nonDerivative · entry 1

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,630

F1 · shares: Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027.

F2 · balance_after: Includes 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
GrantStock Option (Right to Buy) · Derivative 42,500 $0.00 Strike: $76.74 $0.00
Disclosure

SEC source: 0001578852-26-000002 · form4-01062026_050119.xml · derivative · entry 6

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,500

Underlying: Common Stock · 42,500 shares

Expires 2036-01-01

F6 · derivative.exercise_date: This option was granted on January 2, 2026, and vests over four years, with 25% of the shares underlying the option vesting on January 2, 2027, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2027.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
GrantCommon Stock 17,000 $0.00 $0.00
Disclosure

SEC source: 0001578852-26-000002 · form4-01062026_050119.xml · nonDerivative · entry 1

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,901

F1 · shares: Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC
Reeve EmmaDirector
GrantStock Option (Right to Buy) · Derivative 3,475 $0.00 Strike: $76.74 $0.00
Disclosure

SEC source: 0001680329-26-000002 · form4-01062026_050117.xml · derivative · entry 4

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,475

Underlying: Common Stock · 3,475 shares

Expires 2036-01-01

F3 · derivative.exercise_date: This option was granted on January 2, 2026 and vests over one year in twelve equal monthly installments, commencing on February 2, 2026.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC
Reeve EmmaDirector
GrantCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001680329-26-000002 · form4-01062026_050117.xml · nonDerivative · entry 1

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,666

F1 · shares: Restricted stock units granted on January 2, 2026 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 2, 2026 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 2, 2027.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC GrantStock Option (Right to Buy) · Derivative 3,475 $0.00 Strike: $76.74 $0.00
Disclosure

SEC source: 0001433982-26-000002 · form4-01062026_050115.xml · derivative · entry 2

ZELDIS JEROME B · CIK 0001433982 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,475

Underlying: Common Stock · 3,475 shares

Expires 2036-01-01

F2 · derivative.exercise_date: This option was granted on January 2, 2026 and vests over one year in twelve equal monthly installments, commencing on February 2, 2026.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC GrantCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001433982-26-000002 · form4-01062026_050115.xml · nonDerivative · entry 1

ZELDIS JEROME B · CIK 0001433982 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,500

F1 · shares: Restricted stock units granted on January 2, 2026 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 2, 2026 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 2, 2027. The Reporting Person has elected to defer receipt of all vested shares until the earliest to occur of (i) four years from the date of grant and (ii) the earliest to occur of (a) the date that is six months following separation of service from the Issuer, (b) a change in control event and (c) death.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC GrantStock Option (Right to Buy) · Derivative 3,475 $0.00 Strike: $76.74 $0.00
Disclosure

SEC source: 0001918147-26-000002 · form4-01062026_050114.xml · derivative · entry 2

Young Alethia · CIK 0001918147 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,475

Underlying: Common Stock · 3,475 shares

Expires 2036-01-01

F2 · derivative.exercise_date: This option was granted on January 2, 2026 and vests over one year in twelve equal monthly installments, commencing on February 2, 2026.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC GrantCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001918147-26-000002 · form4-01062026_050114.xml · nonDerivative · entry 1

Young Alethia · CIK 0001918147 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,067

F1 · shares: Restricted stock units granted on January 2, 2026 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 2, 2026 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 2, 2027.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC GrantStock Option (Right to Buy) · Derivative 3,475 $0.00 Strike: $76.74 $0.00
Disclosure

SEC source: 0001251553-26-000002 · form4-01062026_050112.xml · derivative · entry 2

SOUTHWELL DAVID P · CIK 0001251553 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,475

Underlying: Common Stock · 3,475 shares

Expires 2036-01-01

F2 · derivative.exercise_date: This option was granted on January 2, 2026 and vests over one year in twelve equal monthly installments, commencing on February 2, 2026.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC GrantCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001251553-26-000002 · form4-01062026_050112.xml · nonDerivative · entry 1

SOUTHWELL DAVID P · CIK 0001251553 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,850

F1 · shares: Restricted stock units granted on January 2, 2026 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 2, 2026 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 2, 2027. The Reporting Person has elected to defer receipt of all vested shares until the earliest to occur of (a) the date that is six months following separation of service from the Issuer, (b) a change in control event and (c) death.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC GrantStock Option (Right to Buy) · Derivative 3,475 $0.00 Strike: $76.74 $0.00
Disclosure

SEC source: 0001742616-26-000002 · form4-01062026_050110.xml · derivative · entry 2

Okey Stephanie · CIK 0001742616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,475

Underlying: Common Stock · 3,475 shares

Expires 2036-01-01

F2 · derivative.exercise_date: This option was granted on January 2, 2026 and vests over one year in twelve equal monthly installments, commencing on February 2, 2026.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC GrantCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001742616-26-000002 · form4-01062026_050110.xml · nonDerivative · entry 1

Okey Stephanie · CIK 0001742616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000

F1 · shares: Restricted stock units granted on January 2, 2026 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 2, 2026 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 2, 2027.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC GrantStock Option (Right to Buy) · Derivative 3,475 $0.00 Strike: $76.74 $0.00
Disclosure

SEC source: 0001579003-26-000002 · form4-01062026_050108.xml · derivative · entry 2

Jacobson Allan Steven · CIK 0001579003 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,475

Underlying: Common Stock · 3,475 shares

Expires 2036-01-01

F2 · derivative.exercise_date: This option was granted on January 2, 2026 and vests over one year in twelve equal monthly installments, commencing on February 2, 2026.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC GrantCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001579003-26-000002 · form4-01062026_050108.xml · nonDerivative · entry 1

Jacobson Allan Steven · CIK 0001579003 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,451

F1 · shares: Restricted stock units granted on January 2, 2026 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 2, 2026 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 2, 2027.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.